Projects

Anna Maria D'URSI Projects

6 Funded projects
Filter
DepartmentDipartimento di Farmacia/DIFARMA
Principal InvestigatorD'URSI Anna Maria (Project Coordinator)
FundingFinanziamenti da bandi nazionali Ministeriali ed altri EEPP
FundersUniversità  degli Studi di SALERNO
MINISTERO DELLA SALUTE
Cost148.064,36 euro
Project duration1 January 2023 - 31 December 2030
Detail
⿢Collect, preparation and metabolomic analysis of SMNο7 mice tissue to outline the specific-organ role of SMN gene in SMA pathology⿢Collection and preparation of biofluids (serum, urine, saliva, faeces) from fibromyalgia patients before and after ketogenic or low glycaemic index diet (LOGI)⿢Use of bioinformatics and biostatistics approach for metabolomics data analysis ⿢Integration of metab
DepartmentDipartimento di Farmacia/DIFARMA
Principal InvestigatorD'URSI Anna Maria (Project Coordinator)
FundingUniversity funds
FundersUniversità  degli Studi di SALERNO
Cost3.816,90 euro
Project duration31 July 2023 - 31 July 2026
Detail
Affiliato Spoke 6 - Biodiversity and human wellbeing (CNR)
DepartmentDipartimento di Farmacia/DIFARMA
Principal InvestigatorGRIMALDI Anna Rita (Collaborazione al Coordinatore)
RASTRELLI Luca (Project Coordinator)
FundingFinanziamenti da bandi nazionali Ministeriali ed altri EEPP
FundersMinistero dell'Università e della Ricerca - MUR
Cost1.887.898,75 euro
Project duration1 September 2022 - 31 August 2025
Detail
Alzheimer's disease (AD), is the most common neurodegenerative disorder of the aging population resulting in progressive cognitive and functional decline. Accumulation of amyloid plaques around neuronal cells is considered a critical pathogenetic event and, in most cases, a hallmark of the pathology. In the attempt to identify anti-AD drug candidates, hundreds of molecules targeting Aß peptides ha
DepartmentDipartimento di Farmacia/DIFARMA
Principal InvestigatorD'URSI Anna Maria (Project Coordinator)
FundingUniversity funds
FundersUniversità  degli Studi di SALERNO
Cost12.000,75 euro
Project duration25 July 2022 - 25 July 2025
Detail
Consulenza Analitico/Scientifica per la caratterizzazione di sostanze di interesse farmaceutico di natura peptidica
DepartmentDipartimento di Farmacia/DIFARMA
Principal InvestigatorD'URSI Anna Maria (Project Coordinator)
FundingThird Party Activities - Research
FundersFRESENIUS KABI IPSUM SRL
Cost35.000,00 euro
Project duration5 February 2024 - 31 December 2024
Detail
The dramatic outcome of the Covid19 pandemic raised the necessity to have a general treatment to limit the evolution to severe infections. The interim result of the first vaccines showing an incomplete efficacy and the new virus variants left a therapeutic space for treatments based on different strategies. Monoclonal antibodies appear to have a promising effect, but because of their high cost the
DepartmentDipartimento di Farmacia/DIFARMA
Principal InvestigatorRODRIQUEZ Manuela (Project Coordinator)
FundingUniversity funds
FundersUniversità  degli Studi di SALERNO
Cost13.342,37 euro
Project duration22 November 2021 - 22 November 2024
Detail

  Data source U-GOV dal 1 Gennaio 2013